Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities
Net earnings (loss)	$ (83,770)	$ 142,121
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	129,227	100,392
Amortization	187,968	40,327
Share-based compensation expense	88,952	40,709
Amortization of discount on convertible debt and debt issuance costs	8,276	4,557
Unrealized losses (gains) on foreign currency remeasurements and transactions	3,988	(1,880)
Loss from equity investments	(740)	(1,393)
Deferred income taxes	(86,232)	3,218
Loss on debt extinguishment	6,835	0
Increase (decrease) in cash from changes in (net of effect of acquisitions):
Accounts receivable	12,647	55,548
Inventories	96,084	(123,748)
Accounts payable	(82,042)	12,752
Contract liabilities	12,078	25,096
Income taxes	24,098	2,598
Accrued compensation and benefits	(24,231)	(35,288)
Other operating net assets (liabilities)	6,930	(24,924)
Net cash provided by operating activities	300,068	240,085
Cash Flows from Investing Activities
Additions to property, plant & equipment	(245,854)	(101,689)
Purchases of businesses, net of cash acquired	(5,488,556)	0
Other investing activities	(2,261)	0
Net cash used in investing activities	(5,736,671)	(101,689)
Cash Flows from Financing Activities
Proceeds from borrowings of Revolving Credit Facility	65,000	0
Proceeds from issuance of Series B Preferred Shares	1,400,000	0
Proceeds from issuance of Senior Notes	0	990,000
Payments on Finisar Notes	0	(14,888)
Payments on convertible notes	(3,561)	0
Payments on existing debt	(65,000)	0
Debt issuance costs	(126,516)	(5,639)
Equity issuance costs	(42,000)	0
Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan	7,749	8,370
Payments in satisfaction of employees' minimum tax obligations	(50,516)	(13,823)
Payment of dividends	(13,800)	(20,708)
Other financing activities	(582)	(1,415)
Net cash provided by financing activities	3,755,557	910,872
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	16,769	8,556
Net increase (decrease) in cash, cash equivalents, and restricted cash	(1,664,277)	1,057,824
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period	2,582,371	1,591,892
Cash, Cash Equivalents, and Restricted Cash at End of Period	918,094	2,649,716
Cash paid for interest	127,039	16,104
Cash paid for income taxes	31,853	22,933
Additions to property, plant & equipment included in accounts payable	47,060	64,098
Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Restricted cash	21,000
Cash, cash equivalents, and restricted cash	913,286	2,649,716
Restricted cash, non-current	4,808	0
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	918,094	2,649,716
Term A Loan
Cash Flows from Financing Activities
Proceeds from borrowing of Term Facility	850,000	0
Payments on existing debt	(1,065,217)	(31,025)
Term B Loan
Cash Flows from Financing Activities
Proceeds from borrowing of Term Facility	$ 2,800,000	$ 0